Terumo Corp
OTC:TRUMY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Terumo Corp (TRUMY) under the Base Case is 15.73 USD per share.
Compared with the current market price of 15.74 USD, the stock appears
Fairly Valued .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Terumo Does
Terumo is a Japanese medical device company that makes products used in hospitals, blood centers, and other healthcare settings. Its main businesses include injection and infusion devices, needles, catheters, cardiac and vascular treatment tools, blood management equipment, and products used to collect, process, and transfuse blood. It also sells related disposable items that healthcare workers use every day.
- Headquarters
- Japan JP
- Employees
- 28 294
- IPO date
- Jun 21, 1982
Balance Sheet
Recent Events
Latest Earnings Call
Aortic recall and Neuro supply constraints drove a downward FY '26 outlook revision, while the Aortic root cause and full impact remained under investigation.
Open the earnings call- EPS
- −¥10.72
- Expected
- −¥13.59
- Surprise
- +21.1%
- Stock, day of the call
- +1.7%
Past 12 months
Continue TRUMY Research
Decided on Terumo? Get an email when TRUMY reaches the price you’d buy at. Free with an account.
Other Terumo listings
What is the Intrinsic Value of one TRUMY stock?
The intrinsic value for
Terumo Corp (TRUMY) under the Base Case is 15.73 USD.
Is TRUMY stock undervalued or overvalued?
Compared with the current market price of 15.74 USD, the stock appears Fairly Valued .